Versoza, Danilo, III. F.

HRN: 28-77-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2026
CEFUROXIME 750MG (VIAL)
04/04/2026
04/11/2026
IV
345mg
Q8
AGE With Moderate Dehydration
Remove - Pending Acceptance
04/04/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
04/04/2026
04/11/2026
ORAL
2ml
QID
Oral Thrush
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: